European Society for Medical Oncology (ESMO) shared a post on LinkedIn:
“ESMO Immuno25:
Sergio Quezada, Scientific Co-Chair, encourages you to present your work in immuno-oncology to an engaged audience eager for innovative solutions.
Deadline: 30 September 2025
This congress is dedicated entirely to immuno-oncology across all tumour types — bringing together cutting-edge science, multidisciplinary expertise, and global perspectives.
New this year!
Horizon sessions: These sessions connect current best practices with future breakthroughs, keeping you at the forefront of innovation. From basic research and translational science to late-stage clinical development, our programme is designed to unite the scientific and medical communities. A dynamic environment where collaboration thrives and real-world impact is prioritised.”
Aurélien Marabelle, Medical Oncologist at Gustave Roussy, and Director of the Laboratory for Research on Translational Immunotherapy (LRTI) of INSERM, shared this post, adding:
“Submit an abstract of your most recent data to the ESMO Immuno-Oncology Congress 2025, which will take place in London this year (10-12 December)!”
More posts featuring ESMO.